In pursuit of innovation to solve healthcare’s most important challenges
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
Our mission
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, groundbreaking technologies that can transform cancer care.
Leadership
Bob Ragusa
Chief Executive Officer and Board Member
Joshua Ofman, MD, MSHS
President
Sir Harpal Kumar
President, Biopharma Business & Europe
Aaron Freidin
Chief Financial Officer
Andy Partridge
Chief Commercial Officer
Paul Ciccolella
Senior Vice President, Research, Development & Operations
Satnam Alag, PhD
Senior Vice President, Software Engineering and Chief Security Officer
Abram Barth JD, MPH
General Counsel
Board of Directors
Gregory (Greg) Summe
Chair of the Board, Chair of Nominating and Governance Committee, Member of Audit Committee and Compensation Committee
Sarah Kravens
Member of the Audit Committee, Compensation Committee, and Nominating and Governance Committee
Steve Mizell
Chair of Compensation Committee, Member of Audit Committee and Nominating and Governance Committee
William (Bill) Chase
Chair of Audit Committee, Member of Compensation Committee and Nominating and Governance Committee
Bob Ragusa
Chief Executive Officer and Board Member